Sanofi Creates ‘Center Of Excellence’ In Pursuit Of mRNA Vaccine Rivals
‘Massive Shifts’ Coming For Sanofi Vaccine Portfolio
Executive Summary
Sanofi is beefing up its investment in mRNA vaccine technology with a €400m annual injection into a dedicated mRNA Center of Excellence as it seeks to be at the forefront of the next generation of candidates.